Best Metastases in the liver Metastases in the liver in Israel: TOP 15 doctors

Dr. Pelles Sharon heads the Gastrointestinal Tumor Institute at Sourasky Medical Center – a leader in liver metastases treatment.

• Specializes in systemic treatment of gastrointestinal cancers
• Trained in oncology at London's Royal Marsden Cancer Center
• Developed new methods for treating pancreatic adenocarcinoma
• Conducted breakthrough molecular research on bile duct tumors

Prof. Merimsky leads the Soft Tissue and Bone Oncology Unit at Sourasky Medical Center – one of Israel's top cancer centers.

• Over 41 years of experience of specialized experience in orthopedic oncology
• Fellowship in sarcoma treatment at Institut Gustave Roussy, Paris
• Senior investigator at Weizmann Institute and Tel Aviv University
• Active member of ESMO's sarcoma faculty
• Published numerous studies on cancer treatment outcomes

Prof. Ido Nachmany heads the Second Surgical Department at Sheba Medical Center. He specializes in HPB and robotic surgery for diseases of the liver, pancreas, and bile ducts, and for gastrointestinal neuroendocrine tumors. He also performs adrenal, spleen, and stomach surgery. Forbes listed him among Israel’s top physicians.

He advances minimally invasive robotic and laparoscopic techniques. The aim is better precision and faster recovery.

Credentials: Senior Lecturer at Tel Aviv University. Member of ASTS and IHPBA. Completed HPB and abdominal transplant fellowships at the Thomas E. Starzl Transplantation Institute. Board certified in General Surgery (Israel), Abdominal Organ Transplantation (ASTS), and HPB Surgery (University of Pittsburgh). He has published in Cancer Research, the Journal of the American College of Surgeons, and the European Journal of Surgical Oncology.

Dr. Einat Shacham‑Shmueli is a senior medical oncologist at the Gastrointestinal Clinic, Cancer Center, Sheba Medical Center. She treats cancers of the colon, stomach, and pancreas. She also manages metastatic disease. She uses precision diagnostics and biomarkers, systemic therapies, and radiotherapy. Care is provided within a multidisciplinary team.

She has authored more than 25 peer‑reviewed papers on GI oncology, tumor biology, and new treatments. Her work includes studies on stenting for malignant colonic obstruction. She serves as an investigator in international programs, including the NCI, the Radiation Therapy Oncology Group, and the Cancer Therapy Evaluation Program.

Education: MD, Tel Aviv University. Oncology residency, Tel Aviv Sourasky Medical Center. Advanced training in GI oncology, UCSF. Accreditations: Board certified in Oncology and Gastroenterology. Member, Israel Society of Oncology and Radiotherapy.

Dr. Yuri Goldes is a general surgeon with more than 20 years of clinical experience. He specializes in upper gastrointestinal and oncologic surgery. He is Deputy Director of the Department of General Surgery and Transplantation at Sheba Medical Center in Tel Aviv. He also leads the Upper GI Surgery Unit. He was named to Forbes Israel’s Best Doctors in 2025. He is ranked among Israel’s Best Gastrointestinal Surgeons by Forbes. In 2019, he received the Israeli Ministry of Health “Best Doctor of the Year” award.

He is an expert in advanced minimally invasive and robotic surgery. He treats diaphragmatic hernia, achalasia, GERD, and gallbladder disease. He also performs oncologic surgery for pancreatic, gastric, and esophageal cancers. He uses laparoscopic and robotic techniques.

He pioneered some of Israel’s first robotic oncologic resections of the stomach and pancreas. He is among a small group worldwide who perform minimally invasive Whipple procedures (pancreaticoduodenectomy) using advanced laparoscopy. He applies methods that improve outcomes and speed recovery. He provides personalized care.

Dr. Ari Raphael leads the Israeli National Genomic Medicine Initiative at Sourasky Medical Center, specializing in advanced oncology treatments.

• Senior lecturer with extensive research in genomics and biomedical informatics
• Primary investigator for multiple clinical trials in lung and breast cancer
• Member of European Society of Medical Oncology (ESMO) and International Association for the Study of Lung Cancer (IASLC)
• Recipient of multiple teaching and research honors

Leads the Medical Oncology Division at Sourasky Medical Center, a leading hospital for complex cancer care.

• Senior oncologist with extensive clinical and research experience
• Expertise in treating metastases in the liver
• Background includes internal medicine for whole-body care
• Fluent in English for clear communication

Director of oncology hospitalization at Tel Aviv Medical Center – Dr. Stepfansky leads a dedicated team for liver metastases cases.

• Over 26 years of experience of experience in oncology
• Specializes in internal medicine and oncology
• Active researcher in clinical trials for new cancer treatments
• Trained at Tel Aviv Medical Center, one of Israel's top hospitals

Dr. Ron Greenberg heads the Colorectal Surgery Department at Sourasky Medical Center. He brings over 35 years of experience of experience as an abdominal surgeon.

• Performs both open and minimally invasive procedures
• Specialist in complex pancreatic surgery like the Whipple procedure
• Leads a dedicated surgical team at a major hospital

32 years of experience of surgical expertise – Dr. Ben-haim specializes in liver and pancreatic cancers at Sourasky Medical Center.

• Performs complex Whipple procedures for gastrointestinal cancers
• Focuses exclusively on oncological surgeries
• Recognized among Israel's top liver cancer specialists

Professor Raanan Berger, MD PhD, is a medical oncologist and radiotherapist. He is Director of the Cancer Center at Sheba Medical Center and heads its clinical research unit. He was listed in Forbes Israel’s “Best Doctors” (2025). He leads the genitourinary oncology program with a focus on prostate cancer. His care includes systemic therapy and radiotherapy in a multidisciplinary, patient-centered model.

He is board-certified in oncology. He earned his MD and PhD at Tel Aviv University and completed his clinical training at Sheba. He then completed a postdoctoral fellowship at Dana-Farber/Harvard, focusing on prostate cancer with Dr. Philip Kantoff and molecular oncology in Dr. William C. Hahn’s lab. He is a member of ESMO and ASCO. He has co-authored more than 20 peer-reviewed papers, including studies on outcomes in high- versus very high-risk prostate cancer and on BRCA1/2 in large cohorts.

Prof. Ben Boursi is a physician in the Gastrointestinal Cancer Department at Sheba Medical Center. He specializes in internal medicine, medical oncology, and cancer epidemiology. He is board certified in internal medicine and medical oncology. He earned a B.Med.Sc (summa cum laude) and an MD (magna cum laude) from Tel Aviv University.

He completed clinical and research fellowships in GI oncology and cancer epidemiology at the University of Pennsylvania. He also completed electives at MD Anderson and Mayo Clinic. He founded the ECOG-ACRIN Microbiome Working Group. His microbiome-oncology research has been published in leading journals, including Science, and highlighted by ASCO.

He developed predictive models for early diagnosis of colorectal and pancreatic cancers. These models are now in clinical evaluation. He holds an academic appointment at Tel Aviv University. He is also an Associate Scholar at the University of Pennsylvania.

Dr. Yaacov Lawrence, MA, MBBS, MRCP, is Chair of Radiation Oncology at Sheba Medical Center. He has nearly 30 years of experience in precision radiation oncology and neuro-oncology.

He is an expert in advanced radiation therapy and radiosurgery. He performs stereotactic radiosurgery for brain tumors. He leads Sheba’s GI Cancer Program in gastrointestinal oncology. He also provides precision care for lung and prostate cancers. He pioneered celiac plexus radiosurgery for severe pain from pancreatic cancer.

Training and credentials: MA and MBBS (Cambridge and UCLH); MRCP (RCP); Radiation Oncology fellowship (Thomas Jefferson University). Honors include the ASCO Young Investigator Award and Fellow of ASTRO (FASTRO). He has authored over 280 publications. He is Director of the Center for Translational Radiation Oncology and an Associate Professor at Tel Aviv University.

Professor Rifaat Safadi leads the liver disease unit at Hadassah Medical Center, specializing in advanced liver treatments with international recognition.

• Trained under Professor Scott Friedman at Sinai School of Medicine in New York
• Member of international liver study associations
• Awarded for research on immune modulation of liver fibrosis
• Author of numerous articles in hepatology
• Head of liver disease unit at Hadassah Medical Center